Gå til hovedindhold
UdbudsScanner
Alle udbud
TED458762-2025

Molecular profiling of pre-diagnostic inflammatory bowel disease serum samples

Ordregiver
Aalborg University
Oplyst værdi / estimat
—
Frist
15.7.2025
Publiceret
14.7.2025
CPV
85111810, 85145000
Leveringssted (NUTS)
anyw-eea

Dataposten opdateret . Datakilder, dækning og beregningsmetode.

Beskrivelse
AAU has received a grant to do molecular profiling on thousands of pre-diagnostic IBD serum samples and matched population controls. This will help to understand IBD aetiology and enable disease prediction. The timelines of the project are driven by the funding agreement with the Foundation funding the project. This is a high-profile project where it is crucial to deliver high-level research. AAU seeks two suppliers to help us deliver on the project – one to do genetic and epigenetic profiling and the other to do metabolomic and proteomic profiling.

Procedure og udbudsmateriale

Oplysninger fra bekendtgørelsen kan dække flere delkontrakter. Listerne nedenfor er separate uddrag; rækkefølgen kobler ikke et kriterium til en beskrivelse eller delkontrakt. Kontrollér krav, vægtning, frister, optioner og eventuelle rettelser i originalmaterialet.

Proceduretype (kildens kode)

  • open

Tildelingskriterier

  • Price
  • Quality

Beskrivelser af tildelingskriterier

  • The sub-criterion "Price" is assessed relatively. The offers are thus assessed in relation to the other offers received. In connection with the final evaluation, a scoring model will be used, where prices are converted into points, which can then be weighted against points for qualitative criteria in an overall assessment. In the price evaluation, AAU will apply the linear consideration: Points for quotation = 10 – (10 x ((TP – LP) / (HP – LP))) TP = Offered Price ("Total Offer Price") LP = Lowest price (lowest "Total Offer Price") HP = 50% higher than LP The method assigns maximum points to the cheapest tender, on a scale from 0 to 10, while other tenders are awarded maximum points with a deduction corresponding to their submission from the cheapest tender. This method will be used in cases where the spread in the prices received is between 0% and 100%. Secondary evaluation method Page 14 af 19 If the prices received turn out to be significantly different than expected, an evaluation method based on a pricing model will instead be used, where the points for the qualitative criteria are converted into prices, which can then be combined with the tender price in the overall evaluation. In that case, AAU will use the OSLO model: Calculated price=Offered price x (1+percentage markup) Percentage markup=Maximum points−Offer points Maximum points x Factor Factor= Weight of qualitative criterionPrice criterion weight First, the qualitative criteria are awarded points on a scale from 0 to 10. Via a conversion factor, the points are converted into an amount and the amount is included as an addition to the price offered, which results in a calculated price. The lowest calculated price will then be the most economically advantageous offer. If an offer achieves maximum points on all qualitative criteria, the surcharge will be 0. The supplement becomes larger the fewer points are obtained. This method will be used in cases where the dispersion in the prices received is more than 100%.
  • Point scale will be used, see the tender specification section 8.2. Offered combination of DNA genotyping and Methylation profiling: weighting 70 %. Basis for assessment is the Tenderer’s offered methods according to requirement specification item 1.5 and 1.9. Evaluation will be based on the points listed in the table in tender specifications section 8.2. Handling of historical samples: weighing 30 %. Basis for assessment is the Tenderer’s description in the requirement specification item 3.1. The more relevant and substantiated approach, the higher the offer will be evaluated.
  • Point scale will be used, see the tender specification section 8.2. Biomarker: weighting 70 %. Basis for assessment is the Tenderer’s description in the requirement specification item 1.3. The evaluation will be based on how relevant the offered biomarker is in relation to the purpose of the overall analysis. Handling of historical samples: weighing 30 %. Basis for assessment is the Tenderer’s description in the requirement specification item 3.1. The more relevant and substantiated approach, the higher the offer will be evaluated.

Aflevering af tilbud

Åbn originaludbud

Andre bekendtgørelser i samme CPV-kategori

Nyeste bekendtgørelser med samme firecifrede CPV-kategori. Listen kan omfatte både åbne udbud og historik.